Fractionated heparins: LMWH or LMMH?
Pelouze, G.A.
Presse Medicale 23(26): 1223
1994
ISSN/ISBN: 0755-4982 PMID: 7831217 Document Number: 437135
Document emailed within 1 workday
Related Documents
Delsart, D.; Chambefort, V.; Decousus, H. 2001: Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins La Revue du Praticien 51(13): 1489-1497Udvardy, M.; Rák, K. 2001: Comments about dosing of low molecular weight heparins (LMWH) Orvosi Hetilap 142(38): 2077-2082
Krasiński, Z.; Urbanek, T.; Krasińska, B.; Kaczmarczyk, J. 2011: Thromboprophylaxis in patients with multiple organ injuries--is there an alternative to low-molecular-weight heparins (LMWH)? Ortopedia, Traumatologia, Rehabilitacja 13(3): 229-240
Gavrishina, E.V.; Dobrovolskii, A.V.; Niyazov, R.R.; Romodanovskii, D.P.; Vasil'ev, A.N. 2015: Good Planning Practice in Preclinical and Clinical Studies of Unfractionated and Fractionated Heparins in Russia as the Basis of Safe and Effective Anticoagulation Therapy Eksperimental'naia i Klinicheskaia Farmakologiia 78(11): 15-20
Bonarelli, S.; Bacchin, M.R.; Frugiuele, I.; Feoli, M.A.; Facchini, F.; Altimari, V. 2015: Dabigatran etexilate and LMWH for the prevention of venous thromboembolism in 532 patients undergoing hip surgery European Review for Medical and Pharmacological Sciences 19(5): 897-903
Palareti, G.; Legnani, C.; Bianchini, B.; Guazzaloca, G.; Maccaferri, M.; Marabini, A.; De Iaco, P.; Marcozzi, S.; Mancini, L.; Orlandi, C. 1989: Pharmacodynamic effects on blood coagulation of a new low molecular weight heparin (alfa-LMWH) in healthy volunteers and gynecological surgery patients International Angiology: a Journal of the International Union of Angiology 8(1): 47-52
Samama, M. 1986: The new heparins Presse Medicale 15(32): 1631-1635
Rosocha, S.; Schmitz-Huebner, U. 1994: Low-molecular heparins Deutsche Medizinische Wochenschrift 119(18): 678
Linda M. Hiebert 2002: Oral Heparins Clinical Laboratory 48(3-4): 111-116
Thies, H.A.; Gins, R.; Kuder, E. 1976: Subcutaneous heparins Die Medizinische Welt 27(46): 2240-2241
Fareed, J.; Hoppensteadt, D.; Jeske, W.; Clarizio, R.; Walenga, J.M. 1998: Low molecular weight heparins: are they different? Canadian Journal of Cardiology 14 Suppl E: 28e-34e
Agnelli, G.; Cosmi, B. 1990: Low molecular weight heparins Medicina 10(1): 9-15
Drouet, L. 1993: Low molecular weight heparins Presse Medicale 22(40): 2002-2008
Ebell, M.H. 1994: Low molecular weight heparins for DVT Journal of Family Practice 39(5): 501-502
Doutremepuich, C.; Puyal, C.; Lalanne, M.C.; Doutremepuich, F.; De Sèze, O. 1990: How to standardize low molecular weight heparins Annales de Biologie Clinique 48(4): 221-225
Mammen, E.F.; Arcelus, J.; Messmore, H.; Altman, R.; Nurmohamed, M.; Eldor, A. 1999: Clinical differentiation of low molecular weight heparins Seminars in Thrombosis and Hemostasis 25(Suppl 3): 135-144
Gallimore, M.J.; Heller, W.; Fuhrer, G.; Wendel, H.; Klaffschenkel, R.; Hoffmeister, H.E. 1993: Contact activation, heparins and cardiopulmonary bypass Thrombosis and Haemostasis 69(1): 92-93
Hunt, D. 1998: Low-molecular-weight heparins in clinical practice Southern Medical Journal 91(1): 2-10
De Lorenzo, F.; Dotsenko, O.; Kakkar, V.V. 2005: Low molecular weight heparins in cardiovascular medicine Minerva Cardioangiologica 53(6): 585-603
Horellou, M.H.; Samama, M. 1991: Low molecular weight heparins in everyday practice Journal des Maladies Vasculaires 16(2): 179-183